A. Hubbard

发表

Value Assignment of the Proposed 2 nd International Standard for von Willebrand Factor, Concentrate, Human (09/182)

M. Hamill, A. Heath, A. Hubbard, 2010 .

Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood

S. Poole, J. Römisch, A. Hubbard, 2001, Critical care medicine.

Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins.

A. Hubbard, C. Jennings, 1987, Thrombosis research.

A Collaborative Study to Establish the 2nd International Standard for Fibrinogen, Plasma

P. Gaffney, A. Hubbard, D. Sands, 2000, Thrombosis and Haemostasis.

Standardization of Protein C in Plasma: Establishment of an International Standard

A. Hubbard, 1988, Thrombosis and Haemostasis.

Standardisation of Protein S in Plasma: Calibration of the 1st International Standard

A. Hubbard, 1997, Thrombosis and Haemostasis.

von Willebrand disease: laboratory aspects of diagnosis and treatment

D. Lillicrap, E. Favaloro, C. Mazurier, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

The effect of phospholipase C on plasma factor VII

A. Hubbard, L. J. Parr, Lynne J. Parr, 1989, British journal of haematology.

Vanadium and copper in clinical solutions of albumin and their potential to damage protein structure.

C. Coudray, J. Gutteridge, A. Hubbard, 1992, Journal of pharmaceutical sciences.

Coagulation and Chromogenic Assays of Factor VIII Activity: General Aspects, Standardization, and Recommendations

T. Barrowcliffe, A. Hubbard, D. Sands, 2002, Seminars in thrombosis and hemostasis.

Potency estimation of recombinant factor VIII: effect of assay method and standard

A. Hubbard, S. Bevan, L. Weller, 2001, British journal of haematology.

Discrepancies in potency assessment of recombinant FVIII concentrates

C. Kessler, U. Martinowitz, C. Lee, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Laboratory diagnosis of von Willebrand disease: results from a prospective and blind study in 32 laboratories worldwide using lyophilized plasmas

C. Sabin, K. Friedman, G. Castaman, 2011, Journal of thrombosis and haemostasis : JTH.

International biological standards for coagulation factors and inhibitors.

A. Hubbard, 2007, Seminars in thrombosis and hemostasis.

Standards and monitoring treatment

S. Kitchen, T. Barrowcliffe, T. Barrowcliffe, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

International Collaborative Study for the Calibration of a Proposed International Standard for thromboplastin, human, plain

A. Tripodi, A. Hubbard, V. Chantarangkul, 2006, Journal of thrombosis and haemostasis : JTH.

Neutralisation of Heparan Sulphate and Low Molecular Weight Heparin by Protamine

A. Hubbard, C. Jennings, 1985, Thrombosis and Haemostasis.

Modification of Factor VIII in Therapeutic Concentrates after Virus Inactivation by Solvent-Detergent and Pasteurisation

M. Di Giambattista, R. Laub, T. Barrowcliffe, 1998, Thrombosis and Haemostasis.

A survey of one‐stage and chromogenic potencies in therapeutic factor VIII concentrates

A. Hubbard, S. Bevan, L. Weller, 2002, British journal of haematology.

Pharmacokinetic In Vivo Comparison Using 1-Stage and Chromogenic Substrate Assays with Two Formulations of Hemofil-M

E. Gomperts, C. Lee, G. Bray, 1996, Thrombosis and Haemostasis.

von Willebrand factor standards for plasma and concentrate testing.

A. Hubbard, 2006, Seminars in thrombosis and hemostasis.

Standardization of von Willebrand factor propeptide: value assignment to the WHO 6th IS Factor VIII/von Willebrand factor, plasma (07/316)

M. Hamill, R. Montgomery, K. Mertens, 2012, Journal of thrombosis and haemostasis : JTH.

Value assignment of the WHO 2nd International Standard von Willebrand factor, concentrate (09/182)

M. Hamill, A. Heath, A. Hubbard, 2011, Journal of thrombosis and haemostasis : JTH.

Measurement of tissue factor pathway inhibitor in normal and post-heparin plasma.

A. Hubbard, E. Gray, L. Weller, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Inhibition of tissue thromboplastin-mediated blood coagulation.

A. Hubbard, C. Jennings, 1986, Thrombosis research.

Recommendations on the potency labelling of factor VIII and factor IX concentrates

J. Dodt, R. Seitz, A. Srivastava, 2013, Journal of thrombosis and haemostasis : JTH.

Potency determination of factor VIII and factor IX for new product labelling and postinfusion testing: challenges for caregivers and regulators

J. Dodt, A. Hubbard, E. Gray, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Potency Labeling of Novel Factor VIII and Factor IX Concentrates: Past Experience and Current Strategy

Anthony R Hubbard, A. Hubbard, 2015, Seminars in Thrombosis & Hemostasis.

Assay of factor VIII concentrates: comparison of the chromogenic and two-stage clotting assays.

S. J. Edwards, T. Barrowcliffe, A. Hubbard, 1986, Thrombosis research.

International reference standards in coagulation.

A. Hubbard, S. Raut, 2010, Biologicals : journal of the International Association of Biological Standardization.

A multi-centre collaborative study on the potency estimation of ReFacto

R. Seitz, T. Barrowcliffe, A. Hubbard, 2003, Thrombosis and Haemostasis.

Activation profiles of factor VIII in concentrates reflect one‐stage/chromogenic potency discrepancies

A. Hubbard, S. Bevan, L. Weller, 2002, British journal of haematology.

Establishment of an International Reference Reagent for standardization of von Willebrand factor binding to recombinant glycoprotein Ib (VWF:GPIbM and VWF:GPIbR)

S. Haberichter, A. Hubbard, 2019, Journal of thrombosis and haemostasis : JTH.

Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316)

M. Hamill, A. Heath, A. Hubbard, 2011, Journal of thrombosis and haemostasis : JTH.

Report on the Factor V:C Calibration of the Proposed WHO 1st IS Factor V Plasma (03/116) and the SSC/ISTH Secondary Coagulation Standard Lot #3 On behalf of the SSC Subcommittee on Factor VIII and Factor IX of the ISTH

A. Hubbard, S. Johnes, L. Weller, 2007 .

Phospholipase C mediated inhibition of factor VII requires triglyceride-rich lipoproteins.

A. Hubbard, L. J. Parr, 1991, Thrombosis research.

Anticoagulant Activities of Pentosan Polysulphate (Hémoclar) Due to Release of Hepatic Triglyceride Lipase (HTGL)

T. Barrowcliffe, D. Thomas, R. Merton, 1986, Thrombosis and Haemostasis.

Standardization of Low Molecular Weight Heparins : A Collaborative Study

T. Barrowcliffe, D. Thomas, A. Hubbard, 1985, Thrombosis and Haemostasis.

Anticoagulant properties in vitro of heparan sulphates.

T. Barrowcliffe, A. Hubbard, C. Jennings, 1984, Thrombosis research.

Impact of residual moisture and formulation on Factor VIII and Factor V recovery in lyophilized plasma reference materials

A. Hubbard, S. Bevan, P. Matejtschuk, 2007, Analytical and bioanalytical chemistry.

Standardization of factor VIII and von Willebrand factor in plasma: calibration of the WHO 5th International Standard (02/150)

A. Heath, A. Hubbard, 2004, Journal of thrombosis and haemostasis : JTH.

Standardisation of Factor VIII and von Willebrand Factor in Plasma: Calibration of the 4th International Standard (97/586)

P. Rigsby, T. Barrowcliffe, A. Hubbard, 2001, Thrombosis and Haemostasis.

PREGNANCY AND FACTOR VII

A. Hubbard, L. J. Parr, M. G. Baines, 1992, British journal of haematology.

Human parvovirus PARV4 in clotting factor VIII concentrates

S. Baylis, A. Hubbard, J. Fryer, 2007, Vox sanguinis.

Procoagulant Activity of T Lymphoblastoid Cells in Extrinsic and Intrinsic Coagulation Systems

R. Thorpe, T. Barrowcliffe, A. Hubbard, 1989, Thrombosis and Haemostasis.

PRQOOAGULANT ACTIVITY OF HUMAN T LYMPHOCYTES IN INTRINSIC AND EXTRINSIC SYSTEMS

T. Barrowcliffe, A. Hubbard, R. Thorpe, 1987, Thrombosis and Haemostasis.

Standardisation of von Willebrand Factor in Therapeutic Concentrates: Calibration of the 1st International Standard for von Willebrand Factor Concentrate (00/514)

C. Mazurier, A. Hubbard, D. Sands, 2002, Thrombosis and Haemostasis.

Measurement of Activated Factor VII Using Soluble Mutant Tissue Factor -Proposal for Standardization

T. Barrowcliffe, A. Hubbard, 1994, Thrombosis and Haemostasis.

An international collaborative study on the INR calibration of freeze‐dried reference plasmas

T. Barrowcliffe, A. Hubbard, J. MacNab, 1999, British journal of haematology.

International Normalized Ratio determination using calibrated reference plasmas

T. Barrowcliffe, A. Hubbard, S. Margetts, 1997, British journal of haematology.

A Collaborative Study on the Measurement of Protein S Antigen in Plasma

A. Hubbard, M. Wong, 1992, Thrombosis and Haemostasis.

Establishment of the WHO 1st International Standard ADAMTS13, plasma (12/252): communication from the SSC of the ISTH

A. Heath, J. K. Kremer Hovinga, A. Hubbard, 2015, Journal of thrombosis and haemostasis : JTH.

Long‐term stability of the Scientific and Standardization Committee Secondary Coagulation Standard (SSC Lot no. 3)

S. Kitchen, A. Hubbard, M. Beeharry, 2011, Journal of thrombosis and haemostasis : JTH.

Requirement of a reference measurement system for the tissue factor-induced coagulation time and the international normalized ratio

S. Kitchen, C. Cobbaert, A. Tripodi, 2018, Clinical chemistry and laboratory medicine.

Long-term stability of international standards for thromboplastin stored at -20°C, -70°C, and -150°C.

A. Hubbard, C. F. Abdoel, A. van den Besselaar, 2015, Thrombosis research.

A collaborative study to establish the 7th International Standard for Factor VIII Concentrate

T. Barrowcliffe, A. Hubbard, S. Bevan, 2005, Journal of thrombosis and haemostasis : JTH.